Market Access Teams

Launch with the right pricing strategy—backed by real payer insights

Build evidence-based market access strategies through systematic stakeholder research. ExtendMed's Health Expert Connect™ platform enables emerging biotech teams to gather comprehensive payer and administrator perspectives that inform pricing decisions and formulary positioning.

Are you making critical pricing decisions without adequate stakeholder input?

You're preparing for launch in that crucial 12-18 month window. You need to validate pricing approaches, understand coverage barriers and build evidence-based value propositions. But coordinating research across multiple payer organizations, hospital systems and pharmacy benefit managers is nearly impossible with scattered tools and one-off meetings.

Each stakeholder conversation happens in isolation. Insights from your first payer focus group don't connect to feedback from hospital administrators three months later. You're trying to synthesize a year's worth of research from disconnected spreadsheets, email summaries and PowerPoint decks. 

A platform that turns fragmented market access research into a strategic advantage

 

Health Expert Connect™ centralizes your entire market access research program. Launch blinded surveys to gather unbiased baseline insights. Host multi-stakeholder focus groups with payers, hospital administrators and PBM representatives. Build evidence-based value propositions grounded in real decision-maker feedback. Synthesize months of research into actionable pricing strategies—all in one system.

The platform supports the sophisticated research methodologies market access specialists need: anonymized feedback collection to reduce bias, systematic multi-month engagement programs that build longitudinal understanding and AI-assisted analysis tools that identify patterns across diverse stakeholder groups.

The result is a launch-ready pricing and access strategies validated by comprehensive stakeholder research, not educated guesses.

 

A few key market access capabilities at a glance

Blinded stakeholder surveys

Launch anonymized surveys that collect unbiased feedback about current treatment landscapes, unmet needs and coverage priorities. Reduce stakeholder bias by enabling candid input about competitive products and formulary concerns. Gather baseline intelligence before deeper focus group engagement begins.

stakeholder survey

Multi-stakeholder focus groups

Facilitate structured discussions with representatives from diverse payer organizations, hospital systems and pharmacy benefit managers across different states and regional markets. Draw out perspectives that reveal priorities, concerns and common themes. Capture both the consensus views and the outlier concerns that could derail formulary inclusion.

focus group

Evidence-based value proposition development

Use systematic stakeholder feedback to craft compelling formulary inclusion cases grounded in real decision-maker perspectives. Demonstrate how your product fills treatment gaps while delivering improved outcomes at competitive costs. Build value messaging refined to address specific payer concerns raised during research.

value propostition development

Research program synthesis

Leverage platform analysis and AI tools to compile insights from surveys, focus groups and discussions conducted over 8-12 month research periods. Identify patterns across multiple stakeholder types and engagement sessions. Turn months of research into cohesive strategic recommendations that guide pricing and access decisions.

research program

Market access specialist enablement

Provide your market access consultants and specialists with an engagement infrastructure. Enable your strategic partners to execute multi-month research programs efficiently while maintaining their expert guidance and methodological rigor. Let specialists focus on strategy while the platform handles logistics and analysis.

exm-WebsiteDesign-MarketAccess-ScreenshotsCropped-19

Prefer a partner, not just another tool?

We're typically brought in by market access consultants who need technology infrastructure to engage stakeholders effectively. Our platform enables specialists to execute year-long research programs that would be prohibitively expensive and logistically complex using traditional in-person approaches.

  • Multi-month research program coordination
  • Blinded survey and anonymized feedback collection
  • Virtual focus group facilitation across diverse stakeholder types
  • Comprehensive insight synthesis with AI-assisted pattern identification
  • Integration with your consultants' strategic frameworks
  • Cost-effective stakeholder reach without travel and venue expenses
Agency collaboration

We collaborate as the technology partner behind your market access specialists. They maintain the client relationship and strategic direction while we provide platform capabilities and coordination support. Your consultants get sophisticated engagement tools without building internal technology capabilities.

See how we help teams like yours

Mediar Therapeutics needed rapid, cross-functional insights in fibrosis. We convened a virtual advisory board of top experts, facilitated real-time collaboration and fast-tracked the feedback loop.

extendmed and mediar logos

A global oncology biopharma used Health Expert Connect™ to orchestrate 1:1s, a dinner forum and follow-ups across ASCO and EHA—centralizing schedules, compliance tracking and KOL analytics to deepen relationships at scale.

An inflammatory-disease company expanding into nephrology ran asynchronous boards, surveys and chart audits to learn the market fast, refine messaging and engage specialists every six weeks—accelerating entry with lower spend.

A small pharma prepping first launch scaled stakeholder engagement with a lean team, mixing virtual meetings and ongoing discussion to surface payer hurdles and patient insights early, de-risk and beat rivals to key KOLs.

jamie arviso ultragenyx profile
Jaime Arvizo Vice President, Head of Medical Affairs

In 25 years of working with vendors, ExtendMed stands at the top of the list. They’re strategic partners, arming my staff with vital statistics and sharing their experience and ideas for the future. They’re nimble and they understand our business. They’ve anticipated issues, recommended new directions and implemented our decisions efficiently.”

ultragenyx-white

Vice President, Group Account DirectorGlobal Medical Comms Firm

We feel your team does the best job out of any vendor we have used for virtual advisory boards.”

Dr. Michael Chang Vice President, Medical Affairs

The virtual format enables more frequent touchpoints while reducing time commitments for busy specialists. We can build relationships and confidence across multiple specialty areas in ways that traditional in-person meetings never could. The platform makes it possible to engage specialists who would never attend a weekend conference but will participate in targeted discussions relevant to their practice."

Better medical engagements in just three steps

Nobody wants to gamble on a complicated new system. That’s why we’ve made getting started with ExtendMed simple and supportive—from first conversation to long-term success.

Express your interest

Tell us about your therapeutic area, competitive landscape and when you're planning to launch. We'll discuss your market access research objectives and stakeholder engagement needs.

Get a tailored demo

We'll demonstrate how Health Expert Connect™ transforms stakeholder engagement for market access research. You'll see exactly how it supports blinded surveys, multi-stakeholder focus groups and comprehensive insight synthesis.

Have better engagements

We'll guide you through research design, stakeholder identification and analysis methodology. Your market access program will have dedicated platform support throughout the 8-12 month engagement cycle.

A few FAQs

Still have questions? Here are answers to the most common ones we hear from clients exploring Health Expert Connect™.

When should we start market access research?

Begin about 12 months before anticipated FDA approval. This timeline allows systematic stakeholder engagement, comprehensive insight gathering and strategy refinement while you're building your commercial team and MSL presence. Market access research running parallel to late-stage development provides launch-ready pricing and access strategies.

Can we conduct blinded research to get unbiased feedback?

Yes. The platform supports anonymized survey collection and blinded focus group approaches. Stakeholders provide candid input about current treatment options, competitive products and coverage priorities without concern about attribution. This reduces bias and encourages honest assessment of your value proposition.

How do you help synthesize insights from multiple engagements?

The platform's analysis and AI tools compile research findings from surveys, focus groups and discussions conducted over 8-12 months. We identify patterns across stakeholder types, flag contradictory feedback and synthesize comprehensive recommendations. You get strategic guidance based on the full body of research, not disconnected meeting summaries.

What types of stakeholders should we engage?

Typical programs include payer representatives from different insurance organizations, hospital administrators, pharmacy benefit managers, health system decision-makers and regional market leaders. Diversity matters—perspectives from different payer types, geographic markets and organizational structures strengthen your understanding of access barriers and formulary priorities.

Do you provide market access expertise or just technology?

We're primarily brought in by companies with market access expertise who need technology infrastructure for stakeholder engagement. The platform enables your consultants and specialists to execute sophisticated research programs efficiently. We provide engagement tools, coordination support and analysis capabilities while your strategic partners maintain methodological direction.

How does this support our case for formulary inclusion?

Stakeholder feedback demonstrates how your product fills treatment gaps identified by payers themselves. You'll articulate value propositions focused on better outcomes at competitive costs compared to existing alternatives—backed by systematic evidence from the decision-makers who control formulary access. This evidence-based approach is far more compelling than manufacturer-created value claims.

What's the typical duration for comprehensive market access research?

Most programs run 8-12 months with multiple stakeholder engagements including baseline surveys, several rounds of focus groups and follow-up validation discussions. This extended timeline accommodates stakeholder schedules, enables repeated touchpoints that build deeper relationships and allows strategy refinement based on evolving feedback.

Ready to build evidence-based market access strategies?

Request a demo today.

No pressure. No spam. Share a few details and we’ll reach out within one business day. And don't worry—we value your privacy as much as you do.